Protective effects of interferon-γ on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells

International Journal of Cancer

Volumn 66, Issue 3, 1996, Pages 393-399

  Sung, Myung Whun ^a,b   Johnson, Jonas T ^a,b   Van Dongen, Guus ^c   Whiteside, Theresa L ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d W1041 Biomedical Science Tower ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIBODY; CYCLOHEXIMIDE; DACTINOMYCIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CARCINOMA, SQUAMOUS CELL; CELL LINE; CYCLOHEXIMIDE; DACTINOMYCIN; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA, RECOMBINANT; KILLER CELLS, NATURAL; MICE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029938117     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960503)66:3<393::AID-IJC21>3.0.CO;2-B     Document Type: Article

References (24)

1. DE BREE, R., ROOS, J.C., QUAK, J.J., DEN HOLLANDER, W., SNOW, G.B. and VAN DONGEN, G.M.A S., Clinical screening of MAbs 323/A3, CSF-25 and K928 for suitability of targeting tumors in the upper aerodigestive and respiratorY tract. Nucl. Med. Comm., 15, 613-617 (1994).
2. DE FRILS, R.U. and GOLUB, S.H., Characteristics and mechanism of IFN-γ-induced protection of human tumor cells from lysis by lymphokine-activated killer cells. J Immunol., 140, 3686-3698 (1988).
3. FADY, C., GARDNER, A.M., GERA, J.F. and LICHTENSTEIN, A., Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neuoverexpressing cells. Cancer Res., 52, 764-769 (1992).
4. FRIBERG, D., BRYANT, J., SHANNON, W. and WHITESIDE, T.L., In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation. Clin Diag. Lab. Immunol., 1, 261-268 (1994).
5. GORELIK, E. and HERBERMAN, R.B., Role of natural killer (NK) cells in the control of tumor growth and metastatic spread. In: R.B. Herberman (ed.), Cancer immunology. innovative approaches to therapy. p. 151, M. Nijhof. New York (1986).
6. HEO, D.S., SNYDERMAN, C.H., GOLLIN, S.M., PAN, S., WALKER, E., DEKA, R., BARNES, E.L., JOHNSON, J.T., HERBERMAN, R.B. and WHITESIDE, T.L., Biology, cytogenetics, and sensitivity of immunologic effector cells of new head and neck squamous cell carcinoma lines. Cancer Res., 49, 5167-5175 (1989).
7. KARRE, K., Express yourself or die: peptides, MHC molecules and NK cells. Science, 267, 978-979 (1995).
8. KOCH, W.M. and RICHTSMEIER, W.J., Lysis of squamous cell carcinoma via antibody-dependent cellular cytotoxicity. Arch. Otolaryngol Head Neck Surg., 115, 669-676 (1989).
9. LEIDEN, J.M., KARPINSKI, B.A., GOTTSCHALK, L. and KORNBLUTH, J., Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression. J. Immunol., 142, 2140-2147 (1989).
10. MALNATI, M.S., PERUZZI, M., PARKER, K.C., BIDDISON, W.E., CICCONE, E., MORETTA, A. and LONG, E.O., Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science, 267, 1016-1018 (1995).
11. MIYATAKE, S., KIKUCHI, H., ODA, Y., NISHIOKA, T., TAKAHASHI, J., KONDOH, S., MATSUMOTO, M., YAMASAKI, T., IWASAKI, K., AOKI, T., KASKURA, S. and NAMBA, Y., Decreased susceptibility of human gliosarcoma cells to lymphokine-activated killer cell cytolysis by gamma-IFN treatment. Cancer Res., 50, 596-600 (1990).
12. ORTALDO, J.R., WOODHOUSE, C., MORGAN, A.C., HERBERMAN, R.B., CHERESH, D.A. and REISFELD, R., Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J. Immunol., 138, 3566-3572 (1987).
13. QUILLET, A., PERESSE, F., MARCHIOL-FOURNIGAULT, C., HAREL-BELLAN, A., BENBUNAN, M., PLOEGH, H. and FRADELIZI, D., Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression: direct demonstration using 2-microglobulin-transfected Daudi cells. J. Immunol., 141, 17-20 (1988).
14. RABINOWICH, H., VITOLO, D., ALTARAC, S., HERBERMAN, R.B. and WHITESIDE, T.L., Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. J. Immunol., 149, 340-349 (1992).
15. RICHTSMEIER, W.J., KOCH, W.M., MCGUIRE, W.P., POOLE, M.E. and CHANG, E.H., Phase I-II study of advanced had and neck squamous cell carcinoma patients with recombinant human interferon gamma. Arch. Otolaryngol. Head Neck Surg, 116, 1271-1277 (1990).
16. RITTER, M. and 15 OTHERS, Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status. Immunology. 81, 569-577 (1994).
17. SACCHI, M., KAPLAN, I., JOHNSON, J.T. and WHITESIDE, T.L., Antiproliferative effects of cytokines of squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 117, 321-326 (1991).
18. STORKUS, W.J., ALEXANDER, J., PAYNE, J.A., DAWSON, J.R. and CRESSWELL, P., Reversal of natural killing susceptibility in target cells expressing transfected class 1 HLA genes.Proc. nat. Acad. Sci. (Wash.), 86, 2361-2364 (1989).
19. SUNG, M.-W., YASUMURA, S., JOHNSON, J.T., VAN DONGEN, G.M.A.S. and WHITESIDE, T.L., Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous cell carcinoma of the had and neck. Int. J. Cancer, 61, 1-9 (1995).
20. VUJANOVIC, N.L., RABINOWICH, H., LEE, Y. J., JOST, L., HERBERMAN, R.B. and WHITESIDE, T.L., Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cell. Immunol., 151, 133-157 (1993).
21. WRIGHT, S. and BONAVIDA, B., Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factor (NKCF). J. Immunol., 130, 2965-2968 (1983).
22. YANASE, M., TSUKAMOTO, T., YOSHIAKI, K., KATO and HASHIMOTO, Y., Decrease in lymphokine-activated killer sensitivity of a human renal-cell carcinoma cell line after cytokine treatment. Cancer Immunol. Immunother., 39, 22-26 (1994).
23. YASUMURA, S., HIRABAYASHI, H., SCHWARTZ, D.R., Toso, J.F., JOHNSON, J.T., HERBERMAN, R.B. and WHITESIDE, T.L., Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res., 53, 1461-1468 (1993).
24. YOKOYAMA, W.M., Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc. natl. Acad. Sci. (Wash.), 92, 3081-3085 (1995).